Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5698118 | Clinical Oncology | 2015 | 8 Pages |
Abstract
Methylation profiling of a panel of three genes that includes MYOD1, ESR1 and hTERT may be useful to predict the response of invasive cervical carcinoma patients treated with standard chemoradiation therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
S. Sood, F.D. Patel, S. Ghosh, A. Arora, L.K. Dhaliwal, R. Srinivasan,